Deshijia has recently announced the acquisition of FYEO Europe B.V., a private refractive surgery platform based in the Netherlands, in a deal valued at approximately €132 million or HKD 1.115 billion. Through this acquisition, Deshijia purchased shares from private equity firm Commited Capital, three Dutch foundations, and a private company. This strategic move allows Deshijia to enter the refractive surgery field and extend its geographic presence beyond Germany, Denmark, the UK, and Hong Kong to include the Netherlands. Refractive surgery involves various procedures to improve vision, with laser surgery being a significant method, and FYEO Europe B.V. is a well-established platform operating across several European countries. This investment is part of Deshijia’s efforts to broaden its business scope and strengthen its position in the health technology sector. Having previously expanded in multiple countries, this acquisition marks a key milestone in Deshijia’s global growth strategy, enhancing its ability to compete in diverse markets and increase the reach of its products and services. Nonetheless, the company must remain mindful of risks associated with healthcare investments, including local regulations, market demands, and technical complexities. Overall, Deshijia’s acquisition of FYEO Europe B.V. will reinforce its global business plans and solidify its presence in the health technology industry.
Source: binance
